{"id":"https://genegraph.clinicalgenome.org/r/183f7855-a6f6-41f7-b6ef-98d1e369ba5dv1.0","type":"EvidenceStrengthAssertion","dc:description":"Human pathogenic *LMNA* variants were first reported in association with autosomal dominant lipodystrophy in 1974 (Dunnigan et al, PMID 4362786). We have curated the inheritance pattern for *LMNA* related lipodystrophy as semidominant because, while most cases are autosomal dominant, a recessive mode of inheritance has been reported very rarely (Soyaltin et al, PMID:32685188, Savage et al, PMID:15298354, Le Dour et al, PMID:21346069).\n\nBoth partial and complete loss of *LMNA* function due to heterozygous and homozygous or compound heterozygous variants in the *LMNA* have been reported. Typical autosomal dominant cases due to heterozygous variants present in exon 8 and 11 of *LMNA* with partial loss of subcutaneous limb and gluteal fat, insulin resistance, diabetes, hypertension and hypertriglyceridemia (Morel et al, PMID:16636128, Akinci et al, PMID:28641778). The occasional recessive cases due to homozygous or compound heterozygous variants are usually present with severe lipodystrophic syndrome with diabetes and /or acanthosis nigricans, liver steatosis, hypertriglyceridemia, lower serum leptin and adiponectin levels, and dilated cardiomyopathy with conduction disturbances (Le Dour et al, PMID:21346069, AndrÃ© et al PMID: 25819867, Treiber et al PMID: 34292171).\n\nAt least 200 lipodystrophy - causing *LMNA* variants (primarily missense than frameshift or nonsense) have been reported in humans. Evidence supporting the association of this gene with lipodystrophy includes case level data, segregation data, and experimental data. The aggregated score for case-level and segregation data is 12 points. Of the over 200 reported, variants in this gene have been curated for this summary in 13 probands in 10 publications (PMIDs: 32686188,19201734, 18041775, 15298354, 16636128, 30177912, 28641778, 32524016, 21346069, 29108996) with 8 cases presenting as familial partial lipodystrophy and 5 cases with congenital generalized lipodystrophy. More evidence is available to support the gene-disease association in the literature, but as the maximum score for genetic evidence (12 points) has been reached; this has not been curated exhaustively. This gene-disease relationship is supported by functional assays, expression studies and functional alterations (Corsa CAS, et al, PMID:34088712, Friesen M et al, PMID:29108996, Fagerberg L et al, PMID:243099898, Wojtanik et al, PMID:19201734). Total points for the experimental evidence are 5.5. Total points for genetic and experimental evidence together are 17.5.\n\nPer criteria outlined by the ClinGen Lumping and Splitting Working Group, we observed both differences in inheritance pattern and phenotypic variability, but also overlap in the implicated variants. Specifically, *LMNA* has two associated lipodystrophy diseases entities, namely the more commonly associated autosomal dominant familial partial lipodystrophy (OMIM:151660), and the more rarely associated autosomal recessive congenital, generalized lipodystrophy.  Because the latter is rare and there is overlap in the implicated variants, these two entities have been lumped in a single curation of lipodystrophy (MONDO: 0006573).  In addition, *LMNA* has several other associated diseases, including but not limited to:  dilated cardiomyopathy (MONDO: 0005021), arrhythmogenic right ventricular cardiomyopathy (ARVC; MONDO: 0016587), Charcot-Marie-Tooth disease (MIM: 5005588), Emery-Dreifuss muscular dystrophy (MIM: 181350 and 616516), and Hutchinson-Gilford progeria (MIM: 176670).  While there is some genetic and phenotypic overlap, there is enough distinction among these phenotypes and their implicated variants that these entities have (dilated cardiomyopathy and ARVC) or will be curated separately.\n\nIn summary, *LMNA* is definitively associated with semidominant lipodystrophy, with most cases presenting as autosomal dominant familial partial lipodystrophy in adolescents and young adults. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/183f7855-a6f6-41f7-b6ef-98d1e369ba5d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2024-10-09T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2024-10-10T15:17:25.886Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b05e90f0-c093-4572-8ec6-c6d4a41b9dec","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74d0dd0d-ccb6-4070-9856-95891026931c","type":"Finding","dc:description":"The transgenic mouse resembles many aspects of human FPLD2. \nCommon features include a lack of fat accumulation, insulin resistance, muscle hypertrophy, and an enlarged, fatty liver.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19201734","rdfs:label":"Transgenic mouse model  ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9dd9ba73-91bf-4ea7-a22c-08d0f2042ec4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/734d57b8-ffe0-40e6-be25-85dabb7bbf9d","type":"Finding","dc:description":"Transgenic LmnaADKO mice exhibit metabolic dysfunction and share many characteristics of FPLD2 with humans, including loss of adipocytes, hyperglycemia, hepatic steatosis, hyperinsulinemia, and virtually undetectable circulating adiponectin and leptin.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34088712","rdfs:label":"Lmna ADKO mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63f57b7c-2ed2-4535-a5c7-55c020f89b25","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/366c3f31-f396-43e4-bb1c-380ffc244a60","type":"FunctionalAlteration","dc:description":"FPLD2-adipocytes exhibit increased basal and stimulated lipolysis as well as increased maximal mitochondrial activity. These molecular abnormalities in iPSC-derived R482W mutant adipocytes may be connected to the disease pathogenesis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29108996","rdfs:label":"iPSC model for R482W mutation of LMNA"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15f01731-b145-4ecc-a113-2d8bf7e4536f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eaf81646-adc0-49b2-a5f5-f733e755b59a","type":"Finding","dc:description":"https://www.ncbi.nlm.nih.gov/gene/4000","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24309898","rdfs:label":"LMNA Expression-NCBI gene","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5},{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e546d38-4176-4950-bf9a-e1b17f422bcd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd173eb8-ca04-42b1-8dfb-c958fccbe9b1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd173eb8-ca04-42b1-8dfb-c958fccbe9b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"heterozygous p.R482W LMNA-mutated cultured fibroblasts prematurely acquired a senescence phenotype with flattened and enlarged cells. (PMID: 21346069).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fd173eb8-ca04-42b1-8dfb-c958fccbe9b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","allele":{"id":"https://genegraph.clinicalgenome.org/r/a821503b-dd09-4c2f-95b3-efffbfb30537","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA017258"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3e546d38-4176-4950-bf9a-e1b17f422bcd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","rdfs:label":"Proband 4.1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a821503b-dd09-4c2f-95b3-efffbfb30537"},"detectionMethod":"Genomic DNA was isolated from peripheral blood cells and direct sequencing was perfored for LMNA, LMNB2, PPARG, PLIN1, AKT2, CIDEC,LIPE, AGPAT2, BSCL2, and CAV1 genes using the Miseq platform.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000831","obo:HP_0003635","obo:HP_0002155","obo:HP_0009125","obo:HP_0001397"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fd173eb8-ca04-42b1-8dfb-c958fccbe9b1_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1a595389-0082-48a1-a8db-0ee51addf759_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/774434ab-2feb-4044-89de-1a3b0e96a387","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/774434ab-2feb-4044-89de-1a3b0e96a387_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","allele":{"id":"https://genegraph.clinicalgenome.org/r/336e6240-93c1-45d1-a17c-674bbdee1296","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA016479"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1a595389-0082-48a1-a8db-0ee51addf759","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","rdfs:label":"Proband 9.1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/336e6240-93c1-45d1-a17c-674bbdee1296"},"detectionMethod":"Genomic DNA was isolated from peripheral blood cells and direct sequencing was perfored for LMNA, LMNB2, PPARG, PLIN1, AKT2, CIDEC,LIPE, AGPAT2, BSCL2, and CAV1 genes using the Miseq platform.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/774434ab-2feb-4044-89de-1a3b0e96a387_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9a2725cf-2492-4f4d-8646-7a757cdac3dc_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41f9d53b-2f26-41c7-bec9-b31d6a4012b4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30177912","rdfs:label":"Montenegro family","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/41f9d53b-2f26-41c7-bec9-b31d6a4012b4","type":"Family","rdfs:label":"Montenegro family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fe5e1e28-c88c-4a06-b2f0-96e38efc8ea8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30177912","rdfs:label":"Montenegro Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/66249411-aa7f-4efe-a2b4-2fa4028a6865","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1744C>T (p.Arg582Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA31015365"}},"detectionMethod":"DNA was extracted from peripheral blood leucocytes and next generation sequencing was done for  monogenic forms of diabetes in addition to the mitochondrial genome.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/85b70342-be26-46ca-835b-d2cabc5820ef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30177912","allele":{"id":"https://genegraph.clinicalgenome.org/r/66249411-aa7f-4efe-a2b4-2fa4028a6865"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Semidominant"},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0002155","obo:HP_0003635","obo:HP_0000831","obo:HP_0009125","obo:HP_0001397"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fe5e1e28-c88c-4a06-b2f0-96e38efc8ea8"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/6b3215ee-dc1f-4a1c-8956-a18ec081e0dc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21346069","rdfs:label":"Le Dour family_ X-6","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/6b3215ee-dc1f-4a1c-8956-a18ec081e0dc","type":"Family","rdfs:label":"Le Dour family_ X-6","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/54728799-56c4-4cc9-ab57-9eb38350f388","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21346069","rdfs:label":"Proband X-6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":46,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f5f6b822-6c95-4bb7-b351-2a03f550b815","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1961dup (p.Thr655AsnfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA020498"}},"detectionMethod":"LMNA sequencing of genomic DNA","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/98eb76a9-73ce-4233-9397-665d9f6452c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21346069","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5f6b822-6c95-4bb7-b351-2a03f550b815"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Semidominant"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001397","obo:HP_0003635","obo:HP_0000831","obo:HP_0002155","obo:HP_0009125"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/54728799-56c4-4cc9-ab57-9eb38350f388"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/5d5132f2-f064-4c3c-ae0c-d60b5418f97e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","rdfs:label":"Akinci_Family 9","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/5d5132f2-f064-4c3c-ae0c-d60b5418f97e","type":"Family","rdfs:label":"Akinci_Family 9","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/1a595389-0082-48a1-a8db-0ee51addf759"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0009125","obo:HP_0003635","obo:HP_0001397","obo:HP_0000831","obo:HP_0002155"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1a595389-0082-48a1-a8db-0ee51addf759"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e759007c-8979-4243-9c5b-cee2b0e1a6dd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16636128","rdfs:label":"Morel family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e759007c-8979-4243-9c5b-cee2b0e1a6dd","type":"Family","rdfs:label":"Morel family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f3f57152-706f-4663-8191-b6444142b5c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16636128","rdfs:label":"Proband 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9c581f1e-3b60-4eb7-b348-e413a61be72d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1488+5G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA017326"}},"detectionMethod":"The coding regions and intron-exon boundaries of the LMNA gene were PCR amplified, purified, and sanger sequenced on an ABI 3730 Automated DNA Sequencer.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4f44bcfd-ffa6-4520-a663-b2208e79e84a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16636128","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c581f1e-3b60-4eb7-b348-e413a61be72d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0009125","obo:HP_0002155","obo:HP_0001397","obo:HP_0000831","obo:HP_0003635"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f3f57152-706f-4663-8191-b6444142b5c0"}},{"id":"https://genegraph.clinicalgenome.org/r/ee409159-af5c-4f89-8644-251ad6625f1a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","rdfs:label":"Kindred B","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/ee409159-af5c-4f89-8644-251ad6625f1a","type":"Family","rdfs:label":"Kindred B","member":{"id":"https://genegraph.clinicalgenome.org/r/8cd6adb5-2467-4147-b3bc-256c43166234","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","rdfs:label":"B1 Pronband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":40,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e8a5b6fc-797a-48a8-b1eb-12e570978d7e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1748C>T (p.Ser583Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA020320"}},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ba957717-b96d-4623-adc0-c3685ef855d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8a5b6fc-797a-48a8-b1eb-12e570978d7e"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001397","obo:HP_0009125","obo:HP_0003635","obo:HP_0000831","obo:HP_0002155"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8cd6adb5-2467-4147-b3bc-256c43166234"}},{"id":"https://genegraph.clinicalgenome.org/r/b54faf75-a57e-4b1a-b411-a419b85345d9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","rdfs:label":"Kindred A","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/b54faf75-a57e-4b1a-b411-a419b85345d9","type":"Family","rdfs:label":"Kindred A","member":{"id":"https://genegraph.clinicalgenome.org/r/0004975d-a9e1-4035-9ce6-63a8a8831928","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","rdfs:label":"A1 Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":38,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e8a5b6fc-797a-48a8-b1eb-12e570978d7e"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8c83d547-3788-46d3-a9f1-53564855ba08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8a5b6fc-797a-48a8-b1eb-12e570978d7e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001397","obo:HP_0000831","obo:HP_0002155","obo:HP_0009125","obo:HP_0003635"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0004975d-a9e1-4035-9ce6-63a8a8831928"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/5aecddb2-c09b-40c4-98c0-63818311a790_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","rdfs:label":"KIndred C","estimatedLodScore":1.45,"family":{"id":"https://genegraph.clinicalgenome.org/r/5aecddb2-c09b-40c4-98c0-63818311a790","type":"Family","rdfs:label":"KIndred C","member":{"id":"https://genegraph.clinicalgenome.org/r/9928c342-0292-43f4-8186-d1cb6369b4ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","rdfs:label":"C1 Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":32,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e8a5b6fc-797a-48a8-b1eb-12e570978d7e"},{"id":"https://genegraph.clinicalgenome.org/r/458ec1a5-7e3b-4feb-9ccf-f1da3c9e015c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1583C>T (p.Thr528Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA017516"}}],"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001397","obo:HP_0000831","obo:HP_0009125","obo:HP_0003635","obo:HP_0002155"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/74ae4dc0-fa97-494e-989b-da09e5659d9e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8a5b6fc-797a-48a8-b1eb-12e570978d7e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/94bf82aa-61a0-4d3e-ac3c-30bf2523bb2a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15298354","allele":{"id":"https://genegraph.clinicalgenome.org/r/458ec1a5-7e3b-4feb-9ccf-f1da3c9e015c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}},"cg:modeOfInheritance":"Semidominant"},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0002155","obo:HP_0003635","obo:HP_0001397","obo:HP_0009125","obo:HP_0000831"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9928c342-0292-43f4-8186-d1cb6369b4ec"}},{"id":"https://genegraph.clinicalgenome.org/r/e486b251-9a4f-4f56-874c-50993a5edb73_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","rdfs:label":"Akinci_Family 4","estimatedLodScore":3.01,"family":{"id":"https://genegraph.clinicalgenome.org/r/e486b251-9a4f-4f56-874c-50993a5edb73","type":"Family","rdfs:label":"Akinci_Family 4","member":{"id":"https://genegraph.clinicalgenome.org/r/3e546d38-4176-4950-bf9a-e1b17f422bcd"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":10,"phenotypes":["obo:HP_0003635","obo:HP_0002155","obo:HP_0001397","obo:HP_0000831","obo:HP_0009125"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3e546d38-4176-4950-bf9a-e1b17f422bcd"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e9ff7e2f-e881-44c9-b354-9ea2c9413f84_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21346069","rdfs:label":"Le Dour family_ XII-1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e9ff7e2f-e881-44c9-b354-9ea2c9413f84","type":"Family","rdfs:label":"Le Dour family_ XII-1","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2c4fef81-4413-4cb2-a038-da3ea447b351","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21346069","rdfs:label":"Proband XII-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f5f6b822-6c95-4bb7-b351-2a03f550b815"},"detectionMethod":"LMNA sequencing of genomic DNA","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0d1a6f48-8f65-4269-a733-999e7fc61759_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21346069","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5f6b822-6c95-4bb7-b351-2a03f550b815"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Autosomal recessive"},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0009125","obo:HP_0001397","obo:HP_0000831","obo:HP_0003635","obo:HP_0002155"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2c4fef81-4413-4cb2-a038-da3ea447b351"}},{"id":"https://genegraph.clinicalgenome.org/r/69964b77-fdb3-43b1-98cd-895fdcba9c2c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","rdfs:label":"Akinci_Family 5","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/69964b77-fdb3-43b1-98cd-895fdcba9c2c","type":"Family","rdfs:label":"Akinci_Family 5","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/8b7c5f17-7472-4bb0-ab0a-5f46216c100d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","rdfs:label":"Proband 5.1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cf8198e6-217e-46b5-9487-bf9978d20345","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.916C>G (p.Leu306Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342817921"}},"detectionMethod":"Genomic DNA was isolated from peripheral blood cells and direct sequencing was perfored for LMNA, LMNB2, PPARG, PLIN1, AKT2, CIDEC,LIPE, AGPAT2, BSCL2, and CAV1 genes using the Miseq platform.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0002155","obo:HP_0001397","obo:HP_0000831","obo:HP_0003635","obo:HP_0009125"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6773e1c4-319f-4336-87f6-811b69bd9ad9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641778","allele":{"id":"https://genegraph.clinicalgenome.org/r/cf8198e6-217e-46b5-9487-bf9978d20345"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001397","obo:HP_0000831","obo:HP_0009125","obo:HP_0002155","obo:HP_0003635"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8b7c5f17-7472-4bb0-ab0a-5f46216c100d"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/54728799-56c4-4cc9-ab57-9eb38350f388_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98eb76a9-73ce-4233-9397-665d9f6452c2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98eb76a9-73ce-4233-9397-665d9f6452c2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A homozygous LMNA p.T655fsX49 mutation leading to expression of a mutated prelamin-A with 48 aberrant C-terminal amino acids, preventing its physiological posttranslational farnesylation\nand maturation.\nIn cultured fibroblasts of the probands, mutated prelamin-A was associated with typical laminopathic nuclear dysmorphies, increased oxidative stress, and premature senescence. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/98eb76a9-73ce-4233-9397-665d9f6452c2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/54728799-56c4-4cc9-ab57-9eb38350f388"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6040f60b-d06f-4e98-bc96-dfc42e3dc992_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bc5277c-da28-49c6-977f-1be3cf095d20","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bc5277c-da28-49c6-977f-1be3cf095d20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32524016","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d50d74a-4ea3-421a-8dbf-daeebd846906","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1456A>G (p.Lys486Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342822711"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6040f60b-d06f-4e98-bc96-dfc42e3dc992","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32524016","rdfs:label":"Proband 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":29,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1d50d74a-4ea3-421a-8dbf-daeebd846906"},"detectionMethod":"A lipodystrophy genetic panel for ADRA2A, AGPAT2, AKT2, BSCL2, CAV1, CAVIN1, CIDEC, FBN1, KCNJ6,LIPE,LMNA,LMNB2,PCYT1A,PIK3R1,PLIN1,POLD1,PPARg,PSMB8,ZMPSTE24 was performed and the LMNA mutation was identified.","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000831","obo:HP_0001733","obo:HP_0003635","obo:HP_0002155","obo:HP_0009125","obo:HP_0001397"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2bc5277c-da28-49c6-977f-1be3cf095d20_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8b7c5f17-7472-4bb0-ab0a-5f46216c100d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6773e1c4-319f-4336-87f6-811b69bd9ad9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6773e1c4-319f-4336-87f6-811b69bd9ad9_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8b7c5f17-7472-4bb0-ab0a-5f46216c100d"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8cd6adb5-2467-4147-b3bc-256c43166234_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba957717-b96d-4623-adc0-c3685ef855d6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba957717-b96d-4623-adc0-c3685ef855d6_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8cd6adb5-2467-4147-b3bc-256c43166234"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0004975d-a9e1-4035-9ce6-63a8a8831928_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c83d547-3788-46d3-a9f1-53564855ba08","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c83d547-3788-46d3-a9f1-53564855ba08_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0004975d-a9e1-4035-9ce6-63a8a8831928"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2c4fef81-4413-4cb2-a038-da3ea447b351_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d1a6f48-8f65-4269-a733-999e7fc61759","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d1a6f48-8f65-4269-a733-999e7fc61759_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"A homozygous LMNA p.T655fsX49 mutation associated with typical laminopathic nuclear dysmorphies, increased oxidative stress, and premature senescence. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0d1a6f48-8f65-4269-a733-999e7fc61759_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2c4fef81-4413-4cb2-a038-da3ea447b351"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fe5e1e28-c88c-4a06-b2f0-96e38efc8ea8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85b70342-be26-46ca-835b-d2cabc5820ef","type":"EvidenceLine","dc:description":"Homozygous ,inherited missense variant with supporting of multiple case evidence","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85b70342-be26-46ca-835b-d2cabc5820ef_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fe5e1e28-c88c-4a06-b2f0-96e38efc8ea8"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9928c342-0292-43f4-8186-d1cb6369b4ec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94bf82aa-61a0-4d3e-ac3c-30bf2523bb2a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94bf82aa-61a0-4d3e-ac3c-30bf2523bb2a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/74ae4dc0-fa97-494e-989b-da09e5659d9e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74ae4dc0-fa97-494e-989b-da09e5659d9e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9928c342-0292-43f4-8186-d1cb6369b4ec"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/3ee21b7f-ee0e-4bab-baef-ef72b7431f21_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/658ab9cc-a47e-4c2b-aa96-8860a1397245","type":"EvidenceLine","dc:description":"R582H in the LMNA gene is a well-known pathogenic variant (homozygous) that has previously been observed in several cases with severe fat loss. Hence the score is different from the default as per EP recommendation.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/658ab9cc-a47e-4c2b-aa96-8860a1397245_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32685188","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b2ea73f-718e-4055-a78a-30bf9574db22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1745G>A (p.Arg582His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA020309"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3ee21b7f-ee0e-4bab-baef-ef72b7431f21","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32685188","rdfs:label":"Soyaltin proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7b2ea73f-718e-4055-a78a-30bf9574db22"},"detectionMethod":"Genetic testing identified a homozygous pathogenic variant p.R582H (c.1745G > A) in LMNA and no pathogenic variants were identified in the AGPAT2 and BSCL2 genes.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0003635","obo:HP_0002155","obo:HP_0001397","obo:HP_0009125","obo:HP_0000831"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/658ab9cc-a47e-4c2b-aa96-8860a1397245_variant_evidence_item"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8b10ac19-50db-4ce9-b40f-7c13c3ec2670_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e0f5256-9b88-4112-8391-c6f377fa0234","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e0f5256-9b88-4112-8391-c6f377fa0234_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18041775","allele":{"id":"https://genegraph.clinicalgenome.org/r/a8104ecc-feb3-429b-88b8-bddb3a30258b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_170707.4(LMNA):c.1411C>G (p.Arg471Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA017206"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8b10ac19-50db-4ce9-b40f-7c13c3ec2670","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18041775","rdfs:label":"Muschke proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a8104ecc-feb3-429b-88b8-bddb3a30258b"},"detectionMethod":"DNA was isolated by standard procedures from leukocytes of the index patient, her sister, and parents. DNA was amplified and direct sequencing of LMNA was carried out with the Autoload Solid Phase Sequencing Kit.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0003635","obo:HP_0009125","obo:HP_0002155","obo:HP_0001397","obo:HP_0000956","obo:HP_0000831"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4e0f5256-9b88-4112-8391-c6f377fa0234_variant_evidence_item"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f3f57152-706f-4663-8191-b6444142b5c0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f44bcfd-ffa6-4520-a663-b2208e79e84a","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f44bcfd-ffa6-4520-a663-b2208e79e84a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This splice mutation was associated with a severe phenotype and altered in vitro function, including inability to interact with emerin and failure to localize at the nuclear envelope.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4f44bcfd-ffa6-4520-a663-b2208e79e84a_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f3f57152-706f-4663-8191-b6444142b5c0"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9191,"specifiedBy":"GeneValidityCriteria11","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/dmX-vFxm4m8","type":"GeneValidityProposition","disease":"obo:MONDO_0006573","gene":"hgnc:6636","modeOfInheritance":"obo:HP_0032113"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9a2725cf-2492-4f4d-8646-7a757cdac3dc-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}